Herpes simplex virus

Last updated: February 23, 2023

Herpes simplex virus

A&D

A&D

Haemophilus influenzae
Mycobacterium tuberculosis (Tuberculosis)
Mycoplasma pneumoniae
Chlamydia trachomatis
Chlamydia pneumoniae
Treponema pallidum (Syphilis)
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
Cytomegalovirus
Parvovirus B19
Human papillomavirus
Influenza virus
HIV (AIDS)
Candida
Cryptococcus neoformans
Pneumocystis jirovecii (Pneumocystis pneumonia)
Aspergillus fumigatus
Plasmodium species (Malaria)
Histoplasmosis
Blastomycosis
Coccidioidomycosis and paracoccidioidomycosis
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous protein synthesis inhibitors
Miscellaneous cell wall synthesis inhibitors
DNA synthesis inhibitors: Fluoroquinolones
Antimalarials
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Herpesvirus medications
Integrase and entry inhibitors
Azoles
Echinocandins
Miscellaneous antifungal medications
Vitamin B12 deficiency
Iron deficiency anemia
Aplastic anemia
Anemia of chronic disease
Autoimmune hemolytic anemia
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Anemia: Clinical
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Alpha-thalassemia
Beta-thalassemia
Hereditary spherocytosis
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Immune thrombocytopenia
Heparin-induced thrombocytopenia
Disseminated intravascular coagulation
Thrombocytopenia: Clinical
Von Willebrand disease
Platelet disorders: Pathology review
Coagulation disorders: Pathology review
Antiplatelet medications
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Bleeding disorders: Clinical
Wiskott-Aldrich syndrome
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Clinical
Hemophilia
B-cell development
B-cell activation, differentiation, and contraction
T-cell development
T-cell activation
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Thymic aplasia
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Adenosine deaminase deficiency
DiGeorge syndrome
Vaccinations: Clinical
Complement deficiency
Myasthenia gravis
Antibody classes
X-linked agammaglobulinemia
Type I hypersensitivity
Anaphylaxis
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Graft-versus-host disease
Chronic granulomatous disease
Hyper IgM syndrome
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Introduction to the immune system
Innate immune system
Cytokines
Somatic hypermutation and affinity maturation
VDJ rearrangement
MHC class I and MHC class II molecules
Lymphomas: Pathology review
Non-Hodgkin lymphoma
Hodgkin lymphoma
Leukemias: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Plasma cell disorders: Pathology review
Complement system

Transcript

Watch video only

Most of the time, when herpes simplex virus or HSV infects a person, there are no symptoms.

In fact, it also usually moves from one person to another in the absence of symptoms, so it can therefore it can move through a population silently.

Once in a while, though, it can cause symptoms, and typically those are in the form of skin and mucous membrane lesions which can be divided into infections “above the waist”—mostly involving the mouth and tongue, and those “below the waist”—involving the genitals.

There are two types of herpes simplex viruses—HSV1 and HSV2—both of which are part of a larger family of enveloped double-stranded DNA viruses: the herpesviridae family.

Generally speaking, HSV1 tends to cause infections above the waist and HSV2 tends to cause infections below the waist, but there’s a lot of crossover because both viruses can cause both types of infections.

Although herpes is most contagious when there are virus-filled lesions present, it can also spread by asymptomatic shedding which means that herpes viruses can be in saliva or genital secretions even when there are no signs of a cold sore or genital lesion.

Typically, when herpes virus lands on a new host, in other words a person that’s never had herpes before, it dives into small cracks in the skin or mucosa and binds to epithelial cell receptors, which triggers those cells to internalize the virus.

Once inside, the virus starts up the lytic cycle, which is where its DNA gets transcribed and translated by cellular enzymes which help to form viral proteins which are packaged into new herpes viruses which can leave to go off and infect neighbouring epithelial cells.

HSV1 and HSV2 also infect nearby sensory neurons, and travel up their axon to the neuron’s cell body to start up the latent cycle.

The sensory neurons of the face have their cell bodies in the trigeminal nuclei and those around the genitalia are located in the sacral nuclei.

So that’s ultimately where the herpes virus settles in—for life!

You see, the sensory neurons aren’t destroyed, instead, they become a permanent home for the herpes virus, and from time to time, the herpes virus makes a few viral copies of itself and sends those virus particles back down the axon so they can get released and infect epithelial cells.

Since the trigeminal and sacral nuclei serve just one side of the face or body, herpes vesicles and ulcers develop on the ipsilateral or same side as the affected nuclei.

This can happen over and over again throughout a person’s lifetime, with classic triggers being things like stress, skin damage, and viral illnesses.

Recurrent episodes are usually less severe than the primary infection, and sometimes there are no symptoms at all.

When there are symptoms, there might be a characteristic tingling or burning sensation, called a prodrome, one or two days before the blisters appear.

In oral and genital herpes, the primary infection is most often asymptomatic.

Having said that, in oral herpes when it does cause symptoms it usually affects children and it causes lesions on the palate, gums, tongue, lip, and facial area, as well as a fever and enlarged lymph nodes.

The lesions themselves are typically clusters of small, painful, fluid-filled blisters, that ooze and ulcerate, and then eventually heal after a few weeks.

In older children and adults, a common symptom is pharyngitis.

Most of the time, like primary infection, reactivation doesn’t cause any symptoms, but when it does, the most common pattern is having a handful of blisters at the vermillion border—the border of the lip—on one side of the face.

These blisters are typically smaller and heal over a week.

With genital herpes, primary infection can cause symptoms like ulcers and pustules which form on the labia majora, labia minora, mons pubis, vaginal mucosa, and cervix in women and on the shaft of the penis in men.